| Infectious Diseases and Mass Gatherings |
16 |
| Travel and the Spread of Drug-Resistant Bacteria |
15 |
| The Current and Future Use of Telemedicine in Infectious Diseases Practice |
15 |
| The Role of Environmental Contamination in the Transmission of Nosocomial Pathogens and Healthcare-Associated Infections |
13 |
| Multidrug-Resistant Pseudomonas Infections: Hard to Treat, But Hope on the Horizon? |
13 |
| Antifungal Resistance: a Concerning Trend for the Present and Future |
12 |
| The Epidemiology, Evolution, and Treatment of KPC-Producing Organisms |
9 |
| An Update on Malaria Rapid Diagnostic Tests |
9 |
| Antimicrobial Stewardship Interventions to Combat Antibiotic Resistance: an Update on Targeted Strategies |
8 |
| Skin and Soft Tissue Infections Due to Nontuberculous Mycobacteria |
8 |
| Immune Monitoring for CMV in Transplantation |
8 |
| Acute Flaccid Paralysis and Enteroviral Infections |
8 |
| Are Non-HIV Malignancies Increased in the HIV-Infected Population? |
7 |
| Advances and Challenges in the Diagnosis and Treatment of Urinary Tract Infections: the Need for Diagnostic Stewardship |
7 |
| Sink-Related Outbreaks and Mitigation Strategies in Healthcare Facilities |
7 |
| Fluoroquinolone Restriction as an Effective Antimicrobial Stewardship Intervention |
7 |
| Biofilm Formations in Pediatric Respiratory Tract Infection Part 2: Mucosal Biofilm Formation by Respiratory Pathogens and Current and Future Therapeutic Strategies to Inhibit Biofilm Formation or Eradicate Established Biofilm |
6 |
| Biofilm Formations in Pediatric Respiratory Tract Infection: Part 1: Biofilm Structure, Role of Innate Immunity in Protection Against and Response to Biofilm, Methods of Biofilm Detection, Pediatric Respiratory Tract Diseases Associated with Mucosal Biofilm Formation |
6 |
| Enterotoxigenic Escherichia coli Infections |
6 |
| Novel Strategies for the Management of Vancomycin-Resistant Enterococcal Infections |
6 |
| Pediatric Antimicrobial Stewardship: State of the Art |
6 |
| Multidrug Resistant Acinetobacter baumannii: Resistance by Any Other Name Would Still be Hard to Treat |
6 |
| Clinical Decision Support Systems and Their Role in Antibiotic Stewardship: a Systematic Review |
6 |
| Hospital-Acquired Infections Under Pay-for-Performance Systems: an Administrative Perspective on Management and Change |
5 |
| The Epidemiology and Prevention of Candida auris |
5 |
| Chikungunya, Dengue, and Zika in Immunocompromised Hosts |
5 |
| Update on HIV Preexposure Prophylaxis: Effectiveness, Drug Resistance, and Risk Compensation |
5 |
| The Current State of Antimicrobial Stewardship: Challenges, Successes, and Future Directions |
5 |
| CMV Prevention and Treatment in Transplantation: What's New in 2019 |
5 |
| Vulvovaginitis Caused by Candida Species Following Antibiotic Exposure |
4 |
| Recognizing and Overcoming Resistance to New Beta-Lactam/Beta-Lactamase Inhibitor Combinations |
4 |
| Acinetobacter Infections in Neonates |
4 |
| Prosthetic Joint Infections: an Update |
4 |
| Update on Tick-Borne Bacterial Diseases in Travelers |
4 |
| Zika Virus-Associated Aseptic Meningitis and Guillain-Barre Syndrome in a Traveler Returning from Latin America: a Case Report and Mini-Review |
4 |
| Diabetic Foot Infections: Update on Management |
4 |
| Prevention Strategies for Recurrent Community-Associated Staphylococcus aureus Skin and Soft Tissue Infections |
4 |
| Carbapenem-Resistant Enterobacteriaceae in Solid Organ Transplantation: Management Principles |
4 |
| Clostridioides difficile-Associated Diarrhea: Infection Prevention Unknowns and Evolving Risk Reduction Strategies |
4 |
| Resistance Trends and Treatment Options in Gram-Negative Ventilator-Associated Pneumonia |
4 |
| Benefits and Risks of Statin Therapy in the HIV-Infected Population |
4 |
| Management of Resistant Trichomoniasis |
4 |
| Outpatient Pediatric Antibiotic Use: a Systematic Review |
3 |
| Advances in Diagnostic Testing that Impact Infection Prevention and Antimicrobial Stewardship Programs |
3 |
| Updates on Nocardia Skin and Soft Tissue Infections in Solid Organ Transplantation |
3 |
| Primary Prevention of Clostridium difficile-Associated Diarrhea: Current Controversies and Future Tools |
3 |
| Evolving Epidemiology of Japanese Encephalitis: Implications for Vaccination |
3 |
| Diagnosis and Management of CMV Colitis |
3 |
| Pharmacokinetic/Pharmacodynamic Considerations of Beta-Lactam Antibiotics in Adult Critically Ill Patients |
3 |
| Recent Innovations in Diagnosis and Treatment of Pediatric Tuberculosis |
3 |
